ANDA 206857, held by Wilshire Pharms Inc. Tiagabine Hydrochloride.
As of Nov 16, 2026, ANDA 206857 (Tiagabine Hydrochloride), held by Wilshire Pharms Inc, was first approved by FDA on Oct 13, 2017, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 13, 2017 | Original application | Approved | None posted |
| Tiagabine Hydrochloride2MG · tablet;oral | Tiagabine Hydrochloride | Discontinued |
| Tiagabine Hydrochloride4MG · tablet;oral | Tiagabine Hydrochloride | Discontinued |
| Tiagabine Hydrochloride12MG · tablet;oral | Tiagabine Hydrochloride | Discontinued |
| Tiagabine Hydrochloride16MG · tablet;oral | Tiagabine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters